RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Mar 19, 2024 |
1 |
-$608K |
4 |
Mar 19, 2024 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 16, 2024 |
3 |
$0 |
4 |
Feb 21, 2024 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 9, 2024 |
6 |
-$97.4K |
4 |
Feb 13, 2024 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 1, 2024 |
3 |
-$72.8K |
4 |
Feb 5, 2024 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Dec 29, 2023 |
2 |
$72.2K |
4 |
Jan 3, 2024 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Dec 5, 2023 |
6 |
-$860K |
4 |
Dec 7, 2023 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Nov 24, 2023 |
3 |
-$309K |
4 |
Nov 28, 2023 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Nov 14, 2023 |
3 |
-$282K |
4 |
Nov 16, 2023 |
Chief Financial Officer |
AGLE |
Aeglea BioTherapeutics, Inc. |
Jun 22, 2023 |
1 |
$0 |
4 |
Jun 30, 2023 |
Director |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Jun 16, 2023 |
2 |
$13.8K |
4 |
Jun 21, 2023 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 11, 2023 |
3 |
-$18.9K |
4 |
Feb 14, 2023 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 9, 2023 |
1 |
-$38.9K |
4/A |
Feb 14, 2023 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 1, 2023 |
2 |
$0 |
4 |
Feb 3, 2023 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Dec 23, 2022 |
1 |
$0 |
4 |
Dec 29, 2022 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Jun 30, 2022 |
3 |
-$30.8K |
4 |
Jul 6, 2022 |
Chief Financial Officer |
AGLE |
Aeglea BioTherapeutics, Inc. |
Jun 7, 2022 |
1 |
$0 |
4 |
Jun 9, 2022 |
Director |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 11, 2022 |
3 |
-$5.08K |
4 |
Feb 15, 2022 |
Chief Financial Officer |
RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Feb 9, 2022 |
2 |
$0 |
4 |
Feb 11, 2022 |
Chief Financial Officer |
AGLE |
Aeglea BioTherapeutics, Inc. |
Nov 12, 2021 |
1 |
$0 |
4 |
Nov 16, 2021 |
Director |
AGLE |
Aeglea BioTherapeutics, Inc. |
Nov 12, 2021 |
0 |
$0 |
3 |
Nov 16, 2021 |
Director |